N-acetyl-L-cysteine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases hospital length of stay
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“However, pooled data from 2 studies assessing hospital LOS indicated a significantly shorter LOS in the NAC group than in the control group (MD = −3.84 days; 95% CI: −7.44 to −0.24; Table 3).”
Quoted verbatim from Clinical effects of N-acetylcysteine in ICU patients with respiratory disease: a systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Critically ill ICU patients with underlying respiratory disease; pooled across 2 randomized trials, NAC in addition to standard care versus placebo or regimens without NAC; reported in days
Effect -3.84 mean difference, 95% CI -7.44 to -0.24
Clinical effects of N-acetylcysteine in ICU patients with respiratory disease: a systematic review and meta-analysis.2026PMID:42780769Permalink
Keep reading
- Everything the graph holds on N-acetyl-L-cysteine
- Every compound studied against Hospital length of stay
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PE3RTF66YK97YZK7EGYS78